Daymark Wealth Partners’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$364K Buy
5,152
+1,071
+26% +$80.2K 0.01% 515
2025
Q4
$322K Buy
4,081
+889
+28% +$70.4K 0.01% 473
2025
Q3
$263K Buy
3,192
+130
+4% +$10.2K 0.01% 519
2025
Q2
$246K Sell
3,062
-234
-7% -$18.1K 0.01% 491
2025
Q1
$265K Sell
3,296
-1,795
-35% -$149K 0.01% 439
2024
Q4
$417K Buy
5,091
+149
+3% +$12.4K 0.02% 356
2024
Q3
$408K Sell
4,942
-546
-10% -$40.8K 0.02% 372
2024
Q2
$385K Buy
+5,488
New +$392K 0.02% 362

Other funds holding MET

Daymark Wealth Partners's MET Position: Q1 2026 in Review

Daymark Wealth Partners increased its MetLife (MET) stake by 26% in Q1 2026, buying an estimated $80.2K and bringing the position to 5,152 shares worth $364K. The position accounts for 0.01% of the portfolio, ranked #515.

Daymark Wealth Partners first reported a position in MET in Q2 2024 and has held it in 8 quarters since. The position peaked at $417K in Q4 2024. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Daymark Wealth Partners held 5,152 shares of MetLife worth $364K as of Q1 2026.
  • Daymark Wealth Partners bought 1,071 MetLife shares in Q1 2026, an estimated $80.2K.
  • MetLife made up 0.01% of Daymark Wealth Partners's portfolio in Q1 2026, its #515 holding.
  • Daymark Wealth Partners first reported a position in MetLife in Q2 2024 and has held it in 8 quarters since.
  • Daymark Wealth Partners's MetLife position peaked at $417K in Q4 2024.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Daymark Wealth Partners's 13F filing for Q1 2026, filed 11 May 2026.